Patrick Mismetti
French Institute of Health and Medical Research
220 Papers
1.3K Citations
Patrick Mismetti is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Medicine & Pulmonary embolism. The author has an hindex of 42, co-authored 203 publications. Previous affiliations of Patrick Mismetti include University of Lyon & Jean Monnet University.
Chat about Author
Papers
Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis
Sam Schulman,Ajay K. Kakkar,Samuel Z. Goldhaber,Sebastian Schellong,Henry Eriksson,Patrick Mismetti,Anita Vedel Christiansen,Jeffrey Friedman,Florence Le Maulf,Nuala Peter,Clive Kearon +10 more
TL;DR: Dabigatran has similar effects on VTE recurrence and a lower risk of bleeding compared with warfarin for the treatment of acute VTE.
942
Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry.
Silvy Laporte,Patrick Mismetti,Hervé Decousus,Fernando Uresandi,Remedios Otero,José Luis Lobo,Manuel Monreal +6 more
TL;DR: The clinical predictors identified in the present study should be included in any clinical risk stratification scheme to optimally adapt the treatment of PE to the risk of the fatal outcome.
Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer.
Giancarlo Agnelli,Daniel J. George,Ajay K. Kakkar,William D. Fisher,Michael R. Lassen,Patrick Mismetti,Patrick Mouret,Umesh Chaudhari,Francesca Lawson,Alexander G.G. Turpie +9 more
TL;DR: Semuloparin reduces the incidence of thromboembolic events in patients receiving chemotherapy for cancer, with no apparent increase in major bleeding.
517
Prevention of Venous Thromboembolism in Internal Medicine with Unfractionated or Low-molecular-weight Heparins: A Meta-analysis of Randomised Clinical Trials
Patrick Mismetti,Silvy Laporte-Simitsidis,Bernard Tardy,Michel Cucherat,Andrea Buchmuller,Daphné Juillard-Delsart,Hervé Decousus +6 more
TL;DR: This meta-analysis of randomised trials studying prophylactic unfractionated and low-molecular-weight heparin in internal medicine shows that heparins are beneficial in the prevention of venous thromboembolism in internal Medicine.
408
Clinical Outcome of Patients With Upper-Extremity Deep Vein Thrombosis: Results From the RIETE Registry†
Francisco José Munoz,Patrick Mismetti,Renzo Poggio,R. Valle,M. Barrón,María Guil,Manuel Monreal +6 more
TL;DR: At presentation, patients with arm DVT have less often clinically overt PE than those with lower-limb DVT, but their 3-month outcome is similar, and those with cancer have the worse outcome.
325